• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淫羊藿苷II通过ROS介导的STAT3/cFLIP信号下调克服黑色素瘤细胞的TRAIL耐药性。

Icariside II overcomes TRAIL resistance of melanoma cells through ROS-mediated downregulation of STAT3/cFLIP signaling.

作者信息

Du Juan, Wu Jinfeng, Fu Xiuqiong, Tse Anfernee Kai-Wing, Li Ting, Su Tao, Yu Zhi-Ling

机构信息

Consun Chinese Medicines Research Centre for Renal Diseases, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong.

Department of Chinese Medicine, Changhai Hospital, The Second Military Medicine University, Shanghai, China.

出版信息

Oncotarget. 2016 Aug 9;7(32):52218-52229. doi: 10.18632/oncotarget.10582.

DOI:10.18632/oncotarget.10582
PMID:27418138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5239546/
Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising antitumor agent. However, many melanoma cells show weak responses to TRAIL. Here, we investigated whether Icariside II (IS), an active component of Herba Epimedii, could potentiate antitumor effects of TRAIL in melanoma cells. Melanoma cells were treated with IS and/or TRAIL and cell death, apoptosis and signal transduction were analyzed. We showed that IS promoted TRAIL-induced cell death and apoptosis in A375 melanoma cells. Mechanistically, IS reduced the expression levels of cFLIP in a phospho-STAT3 (pSTAT3)-dependent manner. Ectopic expression of STAT3 abolished IS-induced cFLIP down-regulation and the associated potentiation of TRAIL-mediated cell death. Moreover, IS-induced reactive oxygen species (ROS) production preceded down-regulation of pSTAT3/cFLIP via activating AKT, and the consequent sensitization of cells to TRAIL. We also found that IS treatment down-regulated cFLIP via ROS-mediated NF-κB pathway. In addition, IS converted TRAIL-resistant melanoma MeWo and SK-MEL-28 cells into TRAIL-sensitive cells. Taken together, our results indicated that IS potentiated TRAIL-induced apoptosis through ROS-mediated down-regulation of STAT3/cFLIP signaling.

摘要

肿瘤坏死因子相关凋亡诱导配体(TRAIL)是一种很有前景的抗肿瘤药物。然而,许多黑色素瘤细胞对TRAIL反应较弱。在此,我们研究了淫羊藿活性成分淫羊藿苷II(IS)是否能增强TRAIL对黑色素瘤细胞的抗肿瘤作用。用IS和/或TRAIL处理黑色素瘤细胞,并分析细胞死亡、凋亡及信号转导情况。我们发现IS可促进TRAIL诱导的A375黑色素瘤细胞死亡和凋亡。机制上,IS以磷酸化信号转导和转录激活因子3(pSTAT3)依赖的方式降低细胞FLICE样抑制蛋白(cFLIP)的表达水平。STAT3的异位表达消除了IS诱导的cFLIP下调及TRAIL介导的细胞死亡增强作用。此外,IS诱导的活性氧(ROS)生成先于通过激活AKT导致的pSTAT3/cFLIP下调以及随后细胞对TRAIL的致敏。我们还发现IS处理通过ROS介导的核因子κB(NF-κB)途径下调cFLIP。另外,IS将对TRAIL耐药的黑色素瘤MeWo和SK-MEL-28细胞转化为对TRAIL敏感的细胞。综上所述,我们的结果表明IS通过ROS介导的STAT3/cFLIP信号下调增强了TRAIL诱导的凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/9315ee2c7261/oncotarget-07-52218-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/8e2ac01c429e/oncotarget-07-52218-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/0fa2fec278cc/oncotarget-07-52218-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/e412263b1b84/oncotarget-07-52218-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/5f511e128a0a/oncotarget-07-52218-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/3af6c9e5631f/oncotarget-07-52218-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/9315ee2c7261/oncotarget-07-52218-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/8e2ac01c429e/oncotarget-07-52218-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/0fa2fec278cc/oncotarget-07-52218-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/e412263b1b84/oncotarget-07-52218-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/5f511e128a0a/oncotarget-07-52218-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/3af6c9e5631f/oncotarget-07-52218-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f84f/5239546/9315ee2c7261/oncotarget-07-52218-g006.jpg

相似文献

1
Icariside II overcomes TRAIL resistance of melanoma cells through ROS-mediated downregulation of STAT3/cFLIP signaling.淫羊藿苷II通过ROS介导的STAT3/cFLIP信号下调克服黑色素瘤细胞的TRAIL耐药性。
Oncotarget. 2016 Aug 9;7(32):52218-52229. doi: 10.18632/oncotarget.10582.
2
Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.抑制cFLIP足以使人黑色素瘤细胞对TRAIL和CD95L介导的凋亡敏感。
Oncogene. 2008 May 15;27(22):3211-20. doi: 10.1038/sj.onc.1210985. Epub 2007 Dec 17.
3
Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression.亚砷酸钠通过上调TRAIL-R1/R2表面水平和下调cFLIP表达来加速TRAIL介导的黑色素瘤细胞凋亡。
Exp Cell Res. 2006 Dec 10;312(20):4120-38. doi: 10.1016/j.yexcr.2006.09.019. Epub 2006 Sep 28.
4
Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells.共济失调毛细血管扩张症突变激酶活性的抑制增强了TRAIL介导的人黑素瘤细胞凋亡。
Cancer Res. 2009 Apr 15;69(8):3510-9. doi: 10.1158/0008-5472.CAN-08-3883. Epub 2009 Apr 7.
5
Indomethacin sensitizes TRAIL-resistant melanoma cells to TRAIL-induced apoptosis through ROS-mediated upregulation of death receptor 5 and downregulation of survivin.吲哚美辛通过 ROS 介导的死亡受体 5 上调和生存素下调使 TRAIL 耐药黑素瘤细胞对 TRAIL 诱导的凋亡敏感。
J Invest Dermatol. 2014 May;134(5):1397-1407. doi: 10.1038/jid.2013.471. Epub 2013 Nov 8.
6
Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.非洲獐牙菜苦素A通过活性氧介导的死亡受体5上调和c-FLIP下调使TRAIL诱导的细胞凋亡敏感化。
Free Radic Biol Med. 2009 Jun 15;46(12):1639-49. doi: 10.1016/j.freeradbiomed.2009.03.022. Epub 2009 Apr 5.
7
Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover.槲皮素通过JNK介导的cFLIP周转使胰腺癌细胞对TRAIL诱导的凋亡敏感。
Int J Biochem Cell Biol. 2016 Sep;78:327-334. doi: 10.1016/j.biocel.2016.07.033. Epub 2016 Jul 28.
8
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.多韦替尼通过 SHP-1 依赖性抑制 STAT3 使肝癌细胞对 TRAIL 和新型抗 DR5 抗体 tigatuzumab 敏感。
Biochem Pharmacol. 2012 Mar 15;83(6):769-77. doi: 10.1016/j.bcp.2011.12.035. Epub 2012 Jan 2.
9
Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells.电离辐射和亚砷酸钠序贯治疗可显著加速TRAIL介导的人黑色素瘤细胞凋亡。
Cancer Res. 2007 Jun 1;67(11):5397-407. doi: 10.1158/0008-5472.CAN-07-0551.
10
Co-treatment of birinapant with TRAIL synergistically induces apoptosis by downregulating cFLIP(L) in MDA-MB-453 cell lines.比尼帕肽与 TRAIL 联合治疗通过下调 MDA-MB-453 细胞系中的 cFLIP(L) 协同诱导细胞凋亡。
Biochem Biophys Res Commun. 2020 Dec 10;533(3):289-295. doi: 10.1016/j.bbrc.2020.09.031. Epub 2020 Sep 18.

引用本文的文献

1
Pharmacological and Therapeutic Potential of a Natural Flavonoid Icariside II in Human Complication.天然黄酮类化合物淫羊藿苷II在人类并发症中的药理及治疗潜力
Curr Drug Targets. 2025;26(5):320-330. doi: 10.2174/0113894501329810241117231839.
2
TRAIL-Sensitizing Effects of Flavonoids in Cancer.黄酮类化合物对癌症的 TRAIL 增敏作用。
Int J Mol Sci. 2023 Nov 22;24(23):16596. doi: 10.3390/ijms242316596.
3
Oxidative Stress-Mediated Programmed Cell Death: a Potential Therapy Target for Atherosclerosis.氧化应激介导的细胞程序性死亡:动脉粥样硬化的潜在治疗靶点。

本文引用的文献

1
Icariside II, a novel phosphodiesterase-5 inhibitor, attenuates streptozotocin-induced cognitive deficits in rats.淫羊藿苷II,一种新型磷酸二酯酶-5抑制剂,可减轻链脲佐菌素诱导的大鼠认知缺陷。
Neuroscience. 2016 Jul 22;328:69-79. doi: 10.1016/j.neuroscience.2016.04.022. Epub 2016 Apr 22.
2
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy.抗程序性死亡蛋白1(PD-1)疗法的神经、呼吸、肌肉骨骼、心脏及眼部副作用。
Eur J Cancer. 2016 Jun;60:210-25. doi: 10.1016/j.ejca.2016.02.024. Epub 2016 Apr 13.
3
Comparative Pharmacokinetics Study of Icariin and Icariside II in Rats.
Cardiovasc Drugs Ther. 2024 Aug;38(4):819-832. doi: 10.1007/s10557-022-07414-z. Epub 2022 Dec 16.
4
Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers.淫羊藿苷II:实体癌中的抗癌潜力与分子靶点
Front Pharmacol. 2021 Apr 26;12:663776. doi: 10.3389/fphar.2021.663776. eCollection 2021.
5
Inhibiting STAT3 signaling is involved in the anti-melanoma effects of a herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos.抑制 STAT3 信号通路参与了由苦参和金银花组成的中药复方的抗黑色素瘤作用。
Sci Rep. 2017 Jun 8;7(1):3097. doi: 10.1038/s41598-017-03351-2.
6
Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death.抑制素的积累是细胞对不同应激刺激的常见反应,并能保护黑色素瘤细胞免受内质网应激和化疗诱导的细胞死亡。
Oncotarget. 2017 Jun 27;8(26):43114-43129. doi: 10.18632/oncotarget.17810.
大鼠中淫羊藿苷和朝藿定乙的比较药代动力学研究
Molecules. 2015 Dec 1;20(12):21274-86. doi: 10.3390/molecules201219763.
4
Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats.淫羊藿苷II改善链脲佐菌素诱导的糖尿病大鼠的糖尿病肾病。
Drug Des Devel Ther. 2015 Sep 7;9:5147-57. doi: 10.2147/DDDT.S90060. eCollection 2015.
5
Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells.淫羊藿苷II靶向癌细胞中的细胞凋亡和多种信号通路
Int J Biol Sci. 2015 Jul 16;11(9):1100-12. doi: 10.7150/ijbs.11595. eCollection 2015.
6
Sensitization of Melanoma Cells for Death Ligand TRAIL Is Based on Cell Cycle Arrest, ROS Production, and Activation of Proapoptotic Bcl-2 Proteins.黑色素瘤细胞对死亡配体TRAIL的致敏作用基于细胞周期阻滞、活性氧生成以及促凋亡Bcl-2蛋白的激活。
J Invest Dermatol. 2015 Nov;135(11):2794-2804. doi: 10.1038/jid.2015.250. Epub 2015 Jul 2.
7
Targeting JAK kinase in solid tumors: emerging opportunities and challenges.靶向实体瘤中的JAK激酶:新出现的机遇与挑战。
Oncogene. 2016 Feb 25;35(8):939-51. doi: 10.1038/onc.2015.150. Epub 2015 May 18.
8
HDAC Inhibition Overcomes Acute Resistance to MEK Inhibition in BRAF-Mutant Colorectal Cancer by Downregulation of c-FLIPL.组蛋白去乙酰化酶抑制通过下调c-FLIPL克服BRAF突变型结直肠癌对MEK抑制的急性耐药。
Clin Cancer Res. 2015 Jul 15;21(14):3230-3240. doi: 10.1158/1078-0432.CCR-14-2701. Epub 2015 Mar 26.
9
Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis.甲基转移酶的抑制作用加速了cFLIP的降解,并使B细胞淋巴瘤细胞对TRAIL诱导的凋亡敏感。
PLoS One. 2015 Mar 4;10(3):e0117994. doi: 10.1371/journal.pone.0117994. eCollection 2015.
10
TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.肿瘤坏死因子相关凋亡诱导配体(TRAIL)通过依赖受体相互作用蛋白1(RIP1)和不依赖RIP1的途径激活应激活化蛋白激酶(JNK)和核因子κB(NF-κB)。
Cell Signal. 2015 Feb;27(2):306-14. doi: 10.1016/j.cellsig.2014.11.014. Epub 2014 Nov 18.